BRS4-FM4-PM9 - Mitochondrial Biogenesis
(Growing New Mitochondria When Demand Rises)
1. Mission & Overview
Mission
Enable formation of new mitochondria so long-term energetic capacity can expand and adapt.
Overview
Drives formation of new mitochondria through pathways such as PGC-1α, AMPK, and related transcriptional regulators (the master signalling network that senses energy demand and triggers organelle expansion) in response to repeated exercise and metabolic stimuli. This adaptive expansion increases mitochondrial density over weeks of consistent stimulus rather than through any single acute intervention. Macronutrient and cofactor sufficiency provide permissive substrate support, but the biogenesis signal itself originates primarily from physical activity.
- Drives new mitochondria formation via PGC-1α and AMPK signalling.
- Increases mitochondrial density over weeks of consistent exercise stimulus.
- Depends on diet for permissive substrate, but the signal originates from activity.
2. Primary Biological Effects
↑ mitochondrial density; ↑ long-term energy capacity; ↑ adaptive energetic reserve
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Rationale: ADHD mitophagy and mitochondrial quality-control reviews link biogenesis/adaptation biology to long-term energetic restoration after repeated metabolic demand — diet and training provide permissive substrate context; direct ADHD biogenesis-outcome trials remain sparse.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Rationale: Expanded mitochondrial density and adaptive remodelling may support metabolic resilience when baseline ADHD mitochondrial function is strained — synthesised from ADHD-specific mitochondrial biomarker and mitophagy literature.
- Key References:
- Evidence Confidence: Low–Medium
4. Levers
Intervention Profile
Intervention Dominance: Lifestyle-Dominant
- NAD⁺-supportive nutrition ← niacin-rich foods and protein-rich whole foods
- Micronutrient support ← whole grains, legumes, leafy greens, animal foods
- Polyphenol-rich foods ← berries, tea, extra virgin olive oil
- Riboflavin (B2) ← dairy, eggs, lean meat
- B3
- Magnesium ← leafy greens, nuts, seeds
-
Amino acids ← fish, eggs, dairy, legumes
-
Fatty acids ← fish, eggs, olive oil, nuts, seeds
-
Glucose ← oats, barley, legumes, fruit
-
B vitamins (B1, B2, B3, B5, B6, B7, B9, B12) ← whole grains, legumes, eggs
-
Iron ← meat, shellfish, legumes
-
Magnesium ← leafy greens, nuts, seeds
1. Food Preparation & Delivery ONLY
- Gentle cooking of marine-fat sources helps limit oxidative degradation of PUFA-rich meal matrices — see Salmon — Preparation, Mackerel — Preparation.
- Pair iron-containing foods with vitamin C and meal-context enhancers to support absorption — see Lentils — Synergies, Spinach — Synergies.
- Prefer minimally refined whole-kernel or whole-flour products where tolerated. — see Whole Grains — Preparation.
- Prioritise adequate sleep and recovery between training sessions to support adaptive mitochondrial remodelling rather than chronic under-recovery (Evidence:Human Mechanistic) [Goodpaster & Sparks, 2017]
- Ensure adequate B-vitamin and magnesium intake through diverse whole foods to support mitochondrial enzyme and cofactor context for adaptive expansion (Evidence:Human Mechanistic) [Tardy et al., 2020; Kyriazis et al., 2022]
- Polyphenol-rich foods may provide secondary experimental support for mitochondrial biogenesis pathways alongside primary training signals (Evidence:Animal Mechanistic) [Davis et al., 2009; Toney et al., 2019]
5. Mechanistic Basis
Summary
Mitochondrial biogenesis is a built adaptation driven primarily by repeated exercise and physiological stress signals, with nutrition providing permissive substrate and cofactor support rather than replacing the training stimulus [Goodpaster & Sparks, 2017; de Guia et al., 2019].
(Adaptation rather than acute fuel effect)
Mitochondrial biogenesis depends on repeated signalling, training stimulus, and recovery rather than a single meal-level intervention. Exercise-linked pathways including AMPK and PGC-1α coordinate transcriptional programmes that increase mitochondrial density over time [Goodpaster & Sparks, 2017; de Guia et al., 2019].
(Diet as permissive context)
Adequate energy intake, B-vitamin support, and magnesium help create the biochemical environment in which adaptive mitochondrial expansion can proceed. Dietary patterns also influence broader mitochondrial physiology, including biogenesis-related signalling contexts [Tardy et al., 2020; Kyriazis et al., 2022].
(Secondary dietary signals)
Polyphenol-related experimental work suggests quercetin and urolithin A may augment mitochondrial biogenesis markers in preclinical models, though these remain complementary to primary lifestyle drivers [Davis et al., 2009; Toney et al., 2019].
(Boundaries of the mechanism)
This PM addresses mitochondrial density expansion — not acute electron transport throughput (BRS4-FM1-PM1 - Electron Transport Chain Function), substrate switching (BRS4-FM3-PM8 - Metabolic Fuel Switching), or rapid phosphagen buffering (BRS4-FM1-PM3 - Creatine–Phosphocreatine Energy Buffering).
(Cross-BRS context)
Because glucose appearance and feeding-state context affect adaptation signalling, this PM links outward to BRS6-FM1-PM1 - Glucose Appearance Kinetics.
5.1 Evidence Highlights
Introduction/Summary
Mitochondrial biogenesis is primarily training-driven. The evidence below highlights polyphenol-linked mitophagy support and why adaptive capacity matters as a longer-horizon energetic reserve.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Higher polyphenol intake and microbial diversity increase urolithin A and related metabolites supporting mitochondrial resilience and mitophagy [Singh et al., 2022]. Urolithin A intervention has been associated with improved mitophagy markers and cognitive endurance [Andreux et al., 2019; Hou et al., 2024]. For this PM, these represent secondary dietary signals complementing primary exercise-driven biogenesis.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Mitochondrial biogenesis depends on repeated exercise and recovery signalling rather than single-meal interventions [Goodpaster & Sparks, 2017; de Guia et al., 2019]. Diet provides permissive cofactor and substrate context; lifestyle remains the dominant lever.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Review literature links impaired mitophagy and mitochondrial homeostasis to ADHD pathophysiology, framing biogenesis and quality-control pathways as longer-horizon energetic reserve biology relevant to neurodevelopmental contexts [Almutairi et al., 2024; Öğütlü et al., 2022].
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS6-FM1-PM1 - Glucose Appearance Kinetics — glucose Appearance Kinetics
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
7. Scoreable Inputs & Modulation Signals
This PM is scoreable primarily through lifestyle-adaptation signals, with diet contributing permissive support.
| Input Category | Example Inputs | PM9 Relevance |
|---|---|---|
| Functional Property Potentials | training_adaptation_support; mitochondrial_cofactor_density | May support biogenesis capacity. |
| Realised Functional States | consistent_training_pattern; adequate_recovery_context | Reflect adaptation conditions relevant to this PM. |
| Preparation Transformations | whole_food_matrix; minimally_processed | Helps preserve supportive nutrient density. |
8. References
- Goodpaster & Sparks (2017) — Metabolic Flexibility in Health and Disease
- de Guia et al. (2019) — Aerobic and Resistance Exercise Training Reverses Age-dependent Decline in NAD+ Salvage Capacity
- Kyriazis et al. (2022) — Impact of Diet Upon Mitochondrial Physiology (Review)
- Tardy et al. (2020) — B Vitamins and Micronutrients in Energy Metabolism
- Davis et al. (2009) — Quercetin and Mitochondrial Biogenesis
- Toney et al. (2019) — Urolithin A and Mitochondrial Biogenesis
- Singh et al. (2022) — Direct Supplementation with Urolithin A Overcomes Limitations of Dietary Exposure
- Andreux et al. (2019) — The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial Health
- Hou et al. (2024) — Urolithin A Improves Cognitive Endurance
- Almutairi et al. (2024) — Mitochondrial Dysfunction and Mitophagy in ADHD
- Öğütlü et al. (2022) — Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder